NCT03278912 Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations Status WITHDRAWN Phase N/A
NCT03264690 Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients Status COMPLETED Phase N/A
NCT03239704 Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT03201445 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease Status TERMINATED Phase PHASE2
NCT03043677 Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells Status COMPLETED Phase N/A
NCT03035058 Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease Status WITHDRAWN Phase PHASE3
NCT02984059 Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02950779 Assessment of Handgrip Strength in Adults With Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT02922192 Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis Status COMPLETED Phase N/A
NCT02862132 Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases Status COMPLETED Phase NA
NCT02861118 A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02861053 Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ? Status TERMINATED Phase NA
NCT02847052 Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease Status TERMINATED Phase N/A
NCT02846961 Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease Status COMPLETED Phase N/A